Evidence map›Paper›PMID 41105343›Full record

ArticleInflammopharmacology2025

Trypsin inhibitor isolated from the seeds of Inga laurina (sw.) Willd decreased inflammatory and nociceptive responses in mice.

Iluska Senna Bonfá, Dalila Dos Santos Lencina, Jéssica de Araújo Isaías Muller, Paloma Kênia de Moraes Berenguel Lossavaro, Mila Marluce Lima Fernandes, Joyce Dos Santos Lencina, Gabriel Silvino de Oliveira Venâncio, Kamylla Fernanda Souza de Souza, Julia Lopes Ribeiro Fredo, Maria Inês Lenz Souza and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Iluska Senna BonfáGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Dalila Dos Santos LencinaGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Jéssica de Araújo Isaías MullerInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Paloma Kênia de Moraes Berenguel LossavaroGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Mila Marluce Lima FernandesGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Joyce Dos Santos LencinaGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Gabriel Silvino de Oliveira VenâncioLaboratory of Pharmacology and Inflammation, Faculty of Pharmaceutical Sciences, Food and Nutrition, UFMS, Campo Grande, MS, Brazil.
Kamylla Fernanda Souza de SouzaLaboratory of Molecular Biology and Cell Culture, Faculty of Pharmaceutical Sciences, Food and Nutrition, UFMS, Campo Grande, MS, Brazil.
Julia Lopes Ribeiro FredoLaboratory of Molecular Biology and Cell Culture, Faculty of Pharmaceutical Sciences, Food and Nutrition, UFMS, Campo Grande, MS, Brazil.
Maria Inês Lenz SouzaLaboratory of Biophysiopharmacology, Institute of Biosciences, UFMS, Campo Grande, MS, Brazil.
Saulo Euclides Silva FilhoGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Edgar Julian Paredes GameroGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.
Ana Cristina JocobowskiLaboratory of Protein Purification and Biological Functions, Faculty of Pharmaceutical Sciences, Food and Nutrition, UFMS, Campo Grande, MS, Brazil.
Maria Ligia Rodrigues MacedoLaboratory of Protein Purification and Biological Functions, Faculty of Pharmaceutical Sciences, Food and Nutrition, UFMS, Campo Grande, MS, Brazil.
Mônica Cristina Toffoli KadriGraduate Program in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil. monica.kadri@ufms.br.ORCID http://orcid.org/0000-0003-4160-4444

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine proteases (SP) are a defence mechanism for neutrophils, they induce recruitment and activation of immune cell, cytokine production and degradation of the extracellular matrix. However, the deregulated activity of SP or their inhibitors can lead to the development of inflammatory diseases. Natural inhibitors of serine proteases (iSP) from plants of the Fabaceae family have shown potential as modulators of inflammation and Inga laurina is a species that has an iSP (ILTi) in its seeds. The aim of this study was to evaluate the anti-inflammatory and antinociceptive response of this inhibitor. The assays performed were leukocyte infiltrate, mast cell degranulation, paw oedema, writhing abdominal, formalin and the determination of cytokines levels were the assays realized. Male Swiss mice, 18-25 g, were distributed in the groups Saline (10 mL/kg); Dexamethasone (0.5 mg/kg); ILTi (0.3; 3 or 30 mg/kg); Dipyrone (500 mg/kg), in the abdominal writhing assay and Morphine (5 mg/kg), in the formalin test. Cytokine levels were determined by flow cytometry. The results showed that ILTi (0.3 mg/kg) reduced the total leukocytes (64.5%) and polymorphonuclear cell infiltrate (74%), mast cell degranulation (30.2 ± 3.2%) and inhibited paw oedema in all times at the doses of 3 and 30 mg/kg. In addition, ILTi reduced IL-6 (35.6%) and TNF (79.2%) levels. In pain models, ILTi attenuated abdominal writhing (56.4%) and paw licking time in both phases (neurogenic, 43.2%; inflammatory, 23. 4%). Cytokine analysis revealed a decrease in IL-6 (35.6%) and TNF (79.2%) levels. These findings indicate that ILTi exhibits anti-inflammatory and antinociceptive effects, possibly through modulation of protease-mediated pathways or the blocking the activation of protease-activated receptors.

Indexed as

Anti-Inflammatory AgentsFabaceaeInflammationNociceptionSeedsTrypsin InhibitorsAnalgesicsAnimalsCytokinesEdemaMaleMast CellsMicePainPlant ExtractsAnalgesicsAnti-Inflammatory AgentsCytokinesPlant ExtractsTrypsin InhibitorsAntinociceptionInflammationKunitz inhibitorPainSerine proteases

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.